RPR-110477

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRPR-110477
Drug Alias NameRPR-110477
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor antagonists
TargetsEndothelin receptor
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRhone-Poulenc SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRhone-Poulenc SA
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A